Jungsil Ro
238 works · 20,170 citations · h-index 59
Top works
- Nucleoprotein complexes that regulate gene expression in adipocyte differentiation: direct participation of c-fos
- Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
- Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
- Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
- A Direct Role for C/EBP and the AP-I-Binding Site in Gene Expression Linked to Adipocyte Differentiation
- Adipocyte P2 gene: developmental expression and homology of 5'-flanking sequences among fat cell-specific genes.
- Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
- Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
- De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
- Micropapillary Component in Lung Adenocarcinoma
- Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
- Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer
- Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis
- A eukaryotic transcriptional represser with carboxypeptidase activity
- Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma.
- Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3)
- Breast cancer subtypes and survival in patients with brain metastases
- Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- Clinical Implications of CYP2D6 Genotypes Predictive of Tamoxifen Pharmacokinetics in Metastatic Breast Cancer
- Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer